We are proud to bring you our 2019 Report on Clinical and Scientific Innovations in Cardiovascular Services. Our cardiologists, interventional cardiologists, and cardiac and vascular surgeons continue to advance treatment for heart disease through programs that are among the largest and most comprehensive in the country. The strength of our programs are rooted in the clinical, scientific, and educational excellence made possible by NewYork-Presbyterian’s affiliation with two renowned medical schools — Columbia University Vagelos College of Physicians and Surgeons and Weill Cornell Medicine.
Our physicians and surgeons are leaders and innovators in the field, working collaboratively to develop and refine minimally invasive techniques that ease recovery for patients while achieving greater survival with fewer complications. These include the ever-growing application of transcatheter interventions; the use of robotics in cardiac surgery; and new drug and devicebased treatments for arrhythmias.
In 2019, we were pleased to welcome Dr. Nir Uriel as Director of Advanced Heart Failure, Cardiac Transplantation and Mechanical Circulatory Support Programs at NewYork-Presbyterian, and Professor of Medicine in the Division of Cardiology at Columbia University Vagelos College of Physicians and Surgeons and Adjunct Professor of Medicine in the Greenberg Division of Cardiology at Weill Cornell Medicine. An internationally recognized leader in heart failure, mechanical circulatory support, and heart transplantation, Dr. Uriel will oversee heart failure programs at NewYork-Presbyterian’s campuses in Manhattan, Queens, Brooklyn, and Westchester, with a goal to increase accessibility of care for those with advanced heart failure throughout the New York area.
We invite you to learn more about the work of our physicians and scientists in heart failure and transplant, structural heart disease, aortic disease, and vascular disease, including recent progress in transcatheter, endovascular, and surgical procedures. With a shared goal of improving the lives of patients, we are committed to extending the boundaries of what is possible in diagnosis, management, and treatment of cardiac and vascular disease.